| Cytotoxic | 1 | 1 | |
| Vitamin D Receptor (VDR) Modulator | 1 | 1 | |
| 17beta-hydroxysteroid dehydrogenase inhibitor | 1 | 1 | |
| Mast Cell Activation Inhibitor | 1 | 1 | |
| DNA Repair Up-regulation | 1 | 1 | |
| Matrix Metalloproteinase-8 Inhibitor | 1 | 1 | |
| Molecular Probes | 1 | 1 | |
| EpCAM surface marker down-regulation | 1 | 1 | |
| Scolicidal | 1 | 1 | |
| Aminopeptidase N (APN/CD13) inhibitor | 1 | 1 | |
| Brain-Associated Sulfotransferase Down-Regulation | 1 | 1 | |
| Oxytocics | 1 | 1 | |
| Interleukin-18 upregulation | 1 | 1 | |
| Topoisomerase I inhibitor | 1 | 1 | |
| Heat Shock Protein Down-Regulation | 1 | 1 | |
| Photosensitizing Agents | 1 | 1 | |
| Cyclin-Dependent Kinase 4 Down-Regulation | 1 | 1 | |
| Leukotriene D4 antagonist | 1 | 1 | |
| Cytotoxins | 1 | 1 | |
| Radiation-Sensitizing Agents | 1 | 1 | |
| Apaf-1/caspase-dependent apoptotic pathway activator | 1 | 1 | |
| NADPH Oxidase Inhibitors | 1 | 1 | |
| Cannabinoid Receptor Antagonist/Inverse Agonist | 1 | 1 | |
| Topoisomerase II Inhibitor | 1 | 1 | |
| PI3K/Akt/signaling suppression | 1 | 1 | |
| Protein Kinase C Inhibitor | 1 | 1 | |
| 5-HTergic | 1 | 1 | |
| Hypomethylating | 1 | 1 | |
| Dopamine Agonists | 1 | 1 | |
| Radiopharmaceuticals | 1 | 1 | |
| Enkephalinase inhibitor | 1 | 1 | |
| Secretagogues: Prolactin Up-Regulation | 1 | 1 | |
| Sulfonation | 1 | 1 | |
| Hematologic Agents | 1 | 1 | |
| PKM2 downregulation | 1 | 1 | |
| Antidepressive Agents: Second-Generation | 1 | 1 | |
| Zinc-dependent metalloproteinase inhibitor | 1 | 1 | |
| 5-Hydroxyeicosatetraenoic acid (5-HETE) Inhibitor | 1 | 1 | |
| Metal Chelation: Copper | 1 | 1 | |
| Enoyl-acyl Carrier Protein (ACP) Reductase Inhibitors | 1 | 1 | |
| Air Pollutants: Radioactive | 1 | 1 | |
| Monocyte chemotattractant protein-1 (MCP-1) Inhibitor | 1 | 1 | |
| Breast cancer resistance protein (BCRP) down-regulation | 1 | 1 | |
| Phosphodiesterase Inhibitors | 1 | 1 | |
| Chondroprotective | 1 | 1 | |
| Antibiotics: Antifungal | 1 | 1 | |
| Platelet aggregation inhibitor: collagen-induced aggregation | 1 | 1 | |
| Human Polymorphonuclear Leukocyte Degranulation Inhibitor | 1 | 1 | |
| Matrix metalloproteinase-14 (MMP-14) inhibitor | 1 | 1 | |
| Hypoxia-inducible factor-1 (HIF-1) inhibitor | 1 | 1 | |
| MicroRNA modulator | 1 | 1 | |
| Superoxide Scavenger | 1 | 1 | |
| Interleukin-15 downregulation | 1 | 1 | |
| p300/NF-κB down-regulation | 1 | 1 | |
| Chemotherapeuticm | 1 | 1 | |
| Phospholipase D Inhibitors | 1 | 1 | |
| Prostaglandin H Synthase-1 (PGHS-1) Inhibits | 1 | 1 | |
| 1-Leucine Uptake Inhibitor | 1 | 1 | |
| IGF-1R expression down-regulation | 1 | 1 | |
| RANK Downregulation | 1 | 1 | |
| Arginase 1 (Arg1) up-regulation | 1 | 1 | |
| Ribonucleotide Reductase Inhibitor | 1 | 1 | |
| Eryptotic | 1 | 1 | |
| Bcl-xL down-regulation | 1 | 1 | |
| Serine Proteinase Inhibitors | 1 | 1 | |
| Expectorants | 1 | 1 | |
| Interleukin-1 beta upregulation | 1 | 1 | |
| Granulocyte Macrophage-Colony Stimulating Factor (GM-CSF) Inhibitor | 1 | 1 | |
| Anti-Psychotic | 1 | 1 | |
| Histamine up-regulation | 1 | 1 | |
| Prostaglandin H Synthase-2 (PGHS-2) Up-Regulation | 1 | 1 | |
| 12-lipoxygenase (12-LOX) | 1 | 1 | |
| Hydroxyheptadecatrienoate (HHT) Inhibitor | 1 | 1 | |
| Disinfectants | 1 | 1 | |
| Psychedelic | 1 | 1 | |
| E-cadherin down-regulation | 1 | 1 | |
| Enzyme Inhibitors: Pancreatic Amylase | 1 | 1 | |
| Survivin Down-Regulation | 1 | 1 | |
| Phosphorylated Rb Down-Regulation | 1 | 1 | |
| PPAR-Gamma Up-Regulation | 1 | 1 | |
| 15-Lipoxygenase (15-LOX) Inhibitor | 1 | 1 | |
| Maspin (Protease Inhibitor) Up-Regulation | 1 | 1 | |
| Matrix Metalloproteinase-7 (MMP-7) Inhibitor | 1 | 1 | |
| Emmenagogue | 1 | 1 | |
| Reactive Oxygen Species (ROS) attenuation | 1 | 1 | |
| Muscle Relaxants: Central | 1 | 1 | |
| Beta-Defensin-2 Up-Regulation | 1 | 1 | |
| Fatty Acid Synthesis Inhibitors | 1 | 1 | |
| Caspase-2 Activation | 1 | 1 | |
| Oxidants | 1 | 1 | |
| Anti-Retroviral Agents | 1 | 1 | |
| PRL-3 Down-Regulation | 1 | 1 | |
| Immunomodulatory: CD8+ Up-regulation | 2 | 1 | |
| Receptor-Related Orphan Receptor (ROR)-Alpha1 Inhibitor | 2 | 1 | |
| Myosin heavy chain alpha (MHCalpha) reducer | 2 | 1 | |
| Estradiol Antagonists | 2 | 1 | |
| Serum ceruloplasmin oxidase reducer | 2 | 1 | |
| Anesthetics | 2 | 1 | |
| Chemokine (C-C motif) Ligand 2 (CCL2) Down-Regulation | 2 | 1 | |
| Interleukin-5 upregulation | 2 | 1 | |
